Tag: Respiratory Problems: Misc.
FDA Approves Uptravi for Pulmonary Arterial Hypertension
Drug found to limit worsening of the disease and reduce the need for hospitalization
Dose-Linked Pulmonary Complications After FFP Infusion
In warfarin reversal, highest risk with more than three units of fresh frozen plasma
Expiratory Snoring Predicts COPD in Sleep Disordered Breathing
Linear combination of mean oxygen saturation, expiratory breathing predicts FEV1
Guidelines Promote Awareness, Use of Pulmonary Rehabilitation
Policy statement issued to enhance implementation, use, and delivery of pulmonary rehabilitation
Depression Ups Readmission Odds for COPD Exacerbation
Reduced one-year readmission with in-hospital tobacco cessation counseling
November 2015 Briefing – Pulmonology
Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for November 2015. This roundup includes the latest...
Factors ID’d That Predict Antibiotic Rx in Pediatric URI
Non-pediatrician clinicians, white race/ethnicity, age 12 to 18 years predict antibiotic prescription
New Drug Looks Promising for Respiratory Syncytial Virus
Amount of virus was reduced 85 to 88 percent, compared with those who received the placebo
Prognostic Biomarkers ID’d in Pulmonary Hypertension
Lower vWF and HDL cholesterol levels, higher NT-pro-BNP-levels linked to death, transplantation
Facilitating Shared Decision-Making Can Cut Antibiotic Use
Interventions that aim to facilitate shared decision-making effective in short term
